Literature DB >> 23303388

Costs, evidence, and value in the Medicare program: the challenges of technology innovation in breast cancer prevention and control.

Jeanne S Mandelblatt1, Anna N A Tosteson, Nicolien T van Ravesteyn.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23303388      PMCID： PMC4071606          DOI： 10.1001/jamainternmed.2013.2127

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  8 in total

1.  Diagnostic accuracy of digital versus film mammography: exploratory analysis of selected population subgroups in DMIST.

Authors:  Etta D Pisano; R Edward Hendrick; Martin J Yaffe; Janet K Baum; Suddhasatta Acharyya; Jean B Cormack; Lucy A Hanna; Emily F Conant; Laurie L Fajardo; Lawrence W Bassett; Carl J D'Orsi; Roberta A Jong; Murray Rebner; Anna N A Tosteson; Constantine A Gatsonis
Journal:  Radiology       Date:  2008-02       Impact factor: 11.105

2.  Cost-effectiveness of digital mammography breast cancer screening.

Authors:  Anna N A Tosteson; Natasha K Stout; Dennis G Fryback; Suddhasatta Acharyya; Benjamin A Herman; Lucy G Hannah; Etta D Pisano
Journal:  Ann Intern Med       Date:  2008-01-01       Impact factor: 25.391

3.  Hanging in the balance: making decisions about the benefits and harms of breast cancer screening among the oldest old without a safety net of scientific evidence.

Authors:  Jeanne S Mandelblatt; Rebecca Silliman
Journal:  J Clin Oncol       Date:  2008-12-15       Impact factor: 44.544

Review 4.  Cancer care, money, and the value of life: whose justice? Which rationality?

Authors:  Daniel P Sulmasy
Journal:  J Clin Oncol       Date:  2007-01-10       Impact factor: 44.544

5.  Model-based analyses to compare health and economic outcomes of cancer control: inclusion of disparities.

Authors:  Sue J Goldie; Norman Daniels
Journal:  J Natl Cancer Inst       Date:  2011-09-06       Impact factor: 13.506

6.  Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement.

Authors: 
Journal:  Ann Intern Med       Date:  2009-11-17       Impact factor: 25.391

7.  Assessing health care use and cost consequences of a new screening modality: the case of digital mammography.

Authors:  Louise M Henderson; Rebecca A Hubbard; Tracy L Onega; Weiwei Zhu; Diana S M Buist; Paul Fishman; Anna N A Tosteson
Journal:  Med Care       Date:  2012-12       Impact factor: 2.983

8.  The cost of breast cancer screening in the Medicare population.

Authors:  Cary P Gross; Jessica B Long; Joseph S Ross; Maysa M Abu-Khalaf; Rong Wang; Brigid K Killelea; Heather T Gold; Anees B Chagpar; Xiaomei Ma
Journal:  JAMA Intern Med       Date:  2013-02-11       Impact factor: 21.873
  8 in total
  2 in total

1.  Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits.

Authors:  Iris Lansdorp-Vogelaar; Roman Gulati; Angela B Mariotto; Clyde B Schechter; Tiago M de Carvalho; Amy B Knudsen; Nicolien T van Ravesteyn; Eveline A M Heijnsdijk; Chester Pabiniak; Marjolein van Ballegooijen; Carolyn M Rutter; Karen M Kuntz; Eric J Feuer; Ruth Etzioni; Harry J de Koning; Ann G Zauber; Jeanne S Mandelblatt
Journal:  Ann Intern Med       Date:  2014-07-15       Impact factor: 25.391

Review 2.  Optimal breast cancer screening strategies for older women: current perspectives.

Authors:  Dejana Braithwaite; Joshua Demb; Louise M Henderson
Journal:  Clin Interv Aging       Date:  2016-02-03       Impact factor: 4.458
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.